DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $153,784,111 | +3.5% | 619,847 | +0.1% | 0.26% | +4.0% |
| Q2 2023 | $148,554,901 | -6.3% | 618,979 | -1.6% | 0.25% | -9.5% |
| Q1 2023 | $158,602,322 | -10.0% | 629,274 | -5.3% | 0.27% | -11.9% |
| Q4 2022 | $176,298,029 | -4.9% | 664,223 | -7.5% | 0.31% | -12.9% |
| Q3 2022 | $185,385,000 | -3.4% | 717,742 | -5.1% | 0.36% | +1.1% |
| Q2 2022 | $191,838,000 | -15.2% | 756,698 | -1.9% | 0.35% | -1.4% |
| Q1 2022 | $226,348,000 | -13.6% | 771,651 | -3.1% | 0.36% | -10.5% |
| Q4 2021 | $261,999,000 | +4.9% | 796,327 | -2.9% | 0.40% | -2.7% |
| Q3 2021 | $249,776,000 | +7.1% | 820,443 | -5.6% | 0.41% | +7.6% |
| Q2 2021 | $233,136,000 | +25.9% | 868,745 | +5.6% | 0.38% | +18.3% |
| Q1 2021 | $185,120,000 | +10.1% | 822,463 | +8.6% | 0.32% | 0.0% |
| Q4 2020 | $168,187,000 | -0.1% | 757,123 | -3.1% | 0.32% | -12.5% |
| Q3 2020 | $168,281,000 | -0.7% | 781,504 | -18.5% | 0.37% | -3.4% |
| Q2 2020 | $169,535,000 | +24.1% | 958,749 | -2.9% | 0.38% | +5.8% |
| Q1 2020 | $136,622,000 | -13.9% | 987,084 | -4.6% | 0.36% | +11.5% |
| Q4 2019 | $158,750,000 | +827.3% | 1,034,337 | +772.6% | 0.32% | +9.9% |
| Q3 2019 | $17,120,000 | +3.4% | 118,538 | +2.3% | 0.29% | +2.4% |
| Q2 2019 | $16,561,000 | +10.4% | 115,873 | +1.9% | 0.29% | +7.1% |
| Q1 2019 | $15,006,000 | +30.7% | 113,659 | +2.1% | 0.27% | +14.0% |
| Q4 2018 | $11,485,000 | -2.4% | 111,374 | +2.8% | 0.24% | +10.8% |
| Q3 2018 | $11,769,000 | +14.0% | 108,303 | +3.5% | 0.21% | +8.2% |
| Q2 2018 | $10,327,000 | +3.5% | 104,650 | +2.7% | 0.20% | +3.2% |
| Q1 2018 | $9,982,000 | +18.7% | 101,947 | +12.5% | 0.19% | +21.0% |
| Q4 2017 | $8,412,000 | +29.1% | 90,630 | +19.3% | 0.16% | +24.6% |
| Q3 2017 | $6,514,000 | +59.9% | 75,939 | +57.3% | 0.13% | +55.6% |
| Q2 2017 | $4,074,000 | +7.5% | 48,272 | +8.9% | 0.08% | +6.6% |
| Q1 2017 | $3,791,000 | +58.2% | 44,318 | +44.0% | 0.08% | +55.1% |
| Q4 2016 | $2,396,000 | +4.1% | 30,781 | +4.8% | 0.05% | +4.3% |
| Q3 2016 | $2,302,000 | -22.7% | 29,362 | -0.4% | 0.05% | -25.4% |
| Q2 2016 | $2,977,000 | -11.9% | 29,473 | -17.2% | 0.06% | -27.6% |
| Q1 2016 | $3,378,000 | -10.4% | 35,604 | -12.3% | 0.09% | -11.2% |
| Q4 2015 | $3,771,000 | -19.5% | 40,604 | -26.1% | 0.10% | -19.7% |
| Q3 2015 | $4,683,000 | -23.2% | 54,951 | -22.9% | 0.12% | -26.1% |
| Q2 2015 | $6,098,000 | -1.3% | 71,250 | -2.1% | 0.16% | -6.8% |
| Q1 2015 | $6,181,000 | -20.0% | 72,801 | -19.2% | 0.18% | -22.0% |
| Q4 2014 | $7,727,000 | +13.9% | 90,146 | +1.0% | 0.23% | +10.7% |
| Q3 2014 | $6,782,000 | -9.0% | 89,268 | -5.7% | 0.20% | -8.1% |
| Q2 2014 | $7,449,000 | +1.4% | 94,614 | -3.4% | 0.22% | -3.5% |
| Q1 2014 | $7,343,000 | -3.6% | 97,907 | -0.8% | 0.23% | -5.7% |
| Q4 2013 | $7,617,000 | +2.9% | 98,659 | -7.6% | 0.24% | -6.5% |
| Q3 2013 | $7,399,000 | +8.7% | 106,727 | -0.7% | 0.26% | +3.6% |
| Q2 2013 | $6,804,000 | – | 107,485 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |